N@N

Alethia Young Maintained (BIIB) at Hold with Decreased Target to $327 on, Oct 15th, 2021

Alethia Young of Cantor Fitzgerald, Maintained "Biogen Inc." (BIIB) at Hold with Decreased Target from $427 to $327 on, Oct 15th, 2021.

Alethia has made no other calls on BIIB in the last 4 months.

There are 9 other peers that have a rating on BIIB. Out of the 9 peers that are also analyzing BIIB, 3 agree with Alethia's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $290 on, Friday, October 8th, 2021
• Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $326 on, Wednesday, September 29th, 2021
• Salim Syed of "Mizuho" Maintained at Hold with Increased Target to $300 on, Monday, August 2nd, 2021

These are the ratings of the 6 analyists that currently disagree with Alethia

---

• Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $447 on, Tuesday, October 12th, 2021
• Michael Yee of "Jefferies" Maintained at Strong Buy with Decreased Target to $400 on, Friday, October 8th, 2021
• Ami Fadia of "Needham" Initiated at Strong Buy and Held Target at $400 on, Thursday, September 23rd, 2021
• Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $442 on, Thursday, September 16th, 2021
• Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $423 on, Tuesday, July 27th, 2021
• Christopher Raymond of "Piper Sandler" Upgraded from Hold to Buy and Increased Target to $450 on, Friday, June 18th, 2021

Contributing Sources

---